Načítá se...

Pseudomyogenic hemangioendothelioma of bone treated with denosumab: a case report

BACKGROUND: Pseudomyogenic hemangioendothelioma (PMHE) is a rare endothelial neoplasm that involves the bones in only 14% of all cases. The optimal treatment strategy has not been established. We herein report a case of primary PMHE in which denosumab treatment showed activity in both imaging studie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Otani, Shinya, Nakayama, Robert, Sekita, Tetsuya, Hirozane, Toru, Asano, Naofumi, Nishimoto, Kazumasa, Sasaki, Aya, Okita, Hajime, Morioka, Hideo, Nakamura, Masaya, Matsumoto, Morio
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6724307/
https://ncbi.nlm.nih.gov/pubmed/31481040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6072-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!